Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis

Clinical and Experimental Rheumatology

Volumn 24, Issue 2 SUPPL. 41, 2006, Pages

  Garcia Unzueta, M Teresa ^a   Martínez Taboada, Victor M ^b   Señarís, Jose Antonio Amado ^a   Rodríguez Valverde, Vicente ^b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Acute phase response; Adrenomedullin; Giant cell arteritis; Polymyalgia rheumatica

Indexed keywords

ADRENOMEDULLIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; HEMOGLOBIN; STEROID;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; GIANT CELL ARTERITIS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RADIOIMMUNOASSAY; REMISSION; RHEUMATIC POLYMYALGIA; STEROID THERAPY;

ACUTE-PHASE REACTION; ADRENOMEDULLIN; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; HEMATOCRIT; HEMOGLOBINS; HUMANS; MIDDLE AGED; PEPTIDES; POLYMYALGIA RHEUMATICA; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX; TEMPORAL ARTERITIS;

EID: 33745698611     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. KITAMURA K, KANGAWA K, KAWAMOTO M et al.: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 92: 553-60.
2. ICHIKI Y, KITAMURA K, KANGAWA K, KAWAMOTO M, MATSUO H, ETO T: Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338: 6-10.
3. NISHIKIMI T, KITAMURA K, SAITO Y et al.: Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994; 24: 600-4.
4. SUGO S, MINAMINO N, KANGAWA K et al.: Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160-66.
5. SCHELL DA, VARI RC, SAMSON WK: Adrenomedullin: a newly discovered hormone controlling fluid and electrolyte homeostasis. Trends Endocrinol Metab 1996; 7: 7-13.
6. ISHIMITSU T, NISHIKIMI T, SAITO Y et al.: Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158-61.
7. CHEUNG B, LEUNG R: Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci 1997; 92: 59-62.
8. FABREGA E, CRESPO J, CASAFONT F et al.: Adrenomedullin in liver transplantation and its relationship with vascular complications. Liver Transpl Surg 1999; 5: 485-90.
9. GARCÍA-UNZUETA MT, MONTALBÁN C, PESQUERA C, BERRAZUETA JR, AMADO JA: Plasma adrenomedullin levels in type 1 diabetes. Diabetes Care 1998; 21: 999-1003.
10. SUGO S, MINAMINO N, SHOJI H et al.: Interleukin-1, tumor necrosis factor and lypopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 207: 25-32.
11. ELSASSER TH, KAHL S: Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microscopy research and technique 2002; 57: 120-9.
12. YUDOH K, MATSUNO H, KIMURA T: Plasma adrenomedullin in rheumatoid arthritis compared with other rheumatic diseases. Arthritis Rheum 1999; 42: 1297-8.
13. CHEUNG BMY, LAU CS, LEUNG RYH, TONG KK, KUMANA CR: Plasma adrenomedullin level in systemic lupus erythematosus. Rheumatology 2000; 39: 804-13.
14. HUSTON KA, HUNDER GG, LIE JT, KENNEDY KH, ELVEBACK LR: Temporal arteritis. A 25 year epidemiological, clinical and pathologic study. Ann Intern Med 1978; 88: 162-7.
15. ARMONA J, RODRÍGUEZ-VALVERDE V, GONZÁLEZ-GAY MA et al.: Arteritis de células gigantes. Estudio de 191 pacientes. Med Clin (Barc) 1995; 105: 734-7.
16. Blockmans D: The use of (18F)fluorodeoxyglucose positron emisión tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 2003; 21 (Suppl. 32): S15-22.
17. MARTINEZ-TABOADA VM, GORONZY JJ, WEYAND CM: Conceptos actuales sobre la patogenia de la arteritis de células gigantes. Rev Esp Reumatol 1994; 21: 293-9.
18. MARTÍNEZ-TABODA VM, BARTOLOME MJ, FERNÁNDEZ-GONZÁLEZ MD, BLANCO R, RODRIGUEZ-VALVERDE V, LOPEZ-HOYOS M: Homocysteine levels in polymyalgia reumática and giant cell arteritis: influence of corticosteroid therapy. Rheumatology 2003; 42: 1055-61.
19. + cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest 1994; 94: 1134-40.
20. ROCHE NE, FULBRIGHT JW, WAGNER AD, HUNDER GG, GORONZY JJ, WEYAND CM: Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993; 6: 1286-94.
21. SALVARANI C, CANTINI F, BOIARDI L, HUNDER GG: Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol 2003; 21 (Suppl. 32): S23-8.
22. CHUANG T-Y, HUNDER GG, ILSTRUP DM, KURLAND LT: Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672-80.
23. HUNDER GG, BLOCH DA, MICHEL BA et al.: The American College of Rheumatology 1990 criteria for the Classification of giant cell arteritis. Arthrirtis Rheum 1990; 33: 1122-28.
24. MARTÍNEZ-TABOADA V, BRACK A, HUNDER GG, GORONZY JJ, WEYAND CM: The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 1996; 23: 1011-14.
25. AMADO JA, FIDALGO I, GARCÍA-UNZUETA MT et al.: Patients with poor preoperative ejection fraction have a higher plasma response of adrenomedullin in response to open Heart surgery. Acta Anaesthesiol Scand 1999; 43: 829-33.
26. SAMSON WK: Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 1999; 61: 363-89.
27. HIRATA Y, MTTAKA C, SATO K et al.: Increased circulating adrenomedullin, a novel vasodilatory peptide in sepsis. J Clin Endocrinol Metab 1996; 81: 1449-53.
28. EHLENZ K, KOCH B, PREUSS P, SIMON B, KOUP I, LANG RE: High levels of circulating adrenomedullin in severe illnes: correlation with C-reactive protein and evidence against the adrenal medulla as site origin. Exp Clin Endocrinol Diabetes 1997; 105: 156-62.
29. KUWASAKO K, KIDA O, KITAMURA K, KATO J, ETO T: Plasma adrenomedullin in cerebrovascular disease: a possible indicator of endothelial injury. Int Angiol 1997; 16: 272-9.
30. MINAMINO N, SHOJI H, SUGO S, KANGAWA K, MATSUO H: Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 211: 686-93.